Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Stroke. 2015 Jun 4;46(7):2000–2006. doi: 10.1161/STROKEAHA.115.009479

Table 1.

SWOT analyses of current stroke and neurovascular imaging.

Favorable Unfavorable
Internal Strengths
- noninvasive imaging of cerebral vessels and perfusion providing insight into stroke pathophysiology
- standardized imaging protocols
- improved technology: rapid, becoming more simple to use
- HIPAA-secure cloud technology
Weaknesses
- perceived complexity of imaging
- potential delay caused by imaging
- cost of imaging
External Opportunities
- need for biomarkers
- imaging may inform medical decision making for stroke prevention, treatment selection and monitoring, rehabilitation tools already exist for widespread image acqusition, transmission and processing
- StrokeNet initiative
- stroke imaging CDEs
- clinical practice often includes serial imaging
- imaging may reduce costs through allowing smaller sample sizes
- imaging may inform adaptive trial design
Threats
- contradictory results of image-guide acute stroke trials, with no central or standardized data collection and no pooled analysis
- no dedicated imaging RFA and no significant, dedicated funding for imaging infrastructure in StrokeNet
- no plans/funding for permanent repository of images beyong trials in StrokeNet
- large computing or memory needs